
David E. Lanfear, MD MS
@dlanfearmd
Vice President of Research and Chief Scientific Officer, Henry Ford Health. Co-director, Center for Individualized and Genomic Medicine Research
ID: 1444441712429092866
02-10-2021 23:19:03
70 Tweet
204 Followers
64 Following

Made it to South Korea and fired up for Heart Failure Seoul 2023/CTC Asia 2023! Especially excited about the HFSA The Korean Society of Heart Failure joint session tomorrow and meeting new colleagues and collaborators. Nancy Sweitzer MDPhD @jteerlinkmd 日本循環器学会 情報広報部会 MUSC Health MUSC Cardiology


Now published in Circ: Heart Failure: Common Variants in FGD5 Increase Hazard of Mortality or Rehospitalization in Patients With Heart Failure From the ASCEND-HF Trial pubmed.ncbi.nlm.nih.gov/37725680/ AHA Council on Genomic and Precision Medicine U-M College of Pharmacy U-M Health Frankel CVC HFSA



Now this is how to do an assessment of value for pharmacists' services! We need more formal CEAs like this based on patient outcomes (⬇︎BP ➡︎ ⬇︎ CVD events) & less cost-avoidance studies based on interventions made. Kudos Dave Dixon, Professor & Chair @VCUPharmacy & coauthors. jamanetwork.com/journals/jaman…



Our turn! Today our PI is sharing latest findings in mitral valve disease biomarkers and omics at the #Biomarkers forum . Happy to share the floor with excellent speakers Thomas Thum and David E. Lanfear, MD MS in a brilliant session!


Nice overview of #pharmacogenetic recommendations in clinical practice guidelines for multiple therapeutic areas: cardiology, pain, general medicine, infectious disease, psych, neuro, oncology academic.oup.com/ajhp/advance-a… ASHP Chad Bousman howard mcleod Sara Rogers STRIPE Collaborative Community

I’m proud to announce Dr. Jim Januzzi’s promotion to Chief Scientific Officer Baim Institute (formerly Harvard Clinical Research Institute or HCRI). BaimInstitute.org Dr. Januzzi is a brilliant clinical researcher and an academic superstar. His groundbreaking work in the




Exciting times: HFH+MSU Health Science Research Building ground breaking. Congrats to our great HFH leaders, Steven N. Kalkanis MD , Adnan Munkarah MD, Robert Riney, and all our MSU partners.



Congestion🚰 assessment in HF: from symptoms, to weights, BNP, invasive pressures....now IVC area? Check out this and other late breakers planned for HFSA in Journal of Cardiac Failure ‼️ Nir Uriel, MD MSc Gabriel Sayer Marat Fudim, MD MHS Anu Lala-Trindade Robert Mentz, MD Stanford Heart Failure, Cardiac Transplant and MCS sciencedirect.com/science/articl…


Exciting news! Our latest research on dilated cardiomyopathy has just been published in Nature Genetics: rdcu.be/d0ZzH A huge thank you to our incredible HERMES collaborators for making this possible. hermesconsortium.org James Ware Sean Zheng Albert Henry

🚨 Our latest GWAS of heart failure subtypes is now out in Nature Genetics! rdcu.be/eb9O0 A massive global collaboration from HERMES Consortium involving >40 studies with >150,000 heart failure cases. HERMES Consortium Tom Lumbers 🧵 highlighting key findings 1/

Harnessing the Plasma Proteome to Predict Mortality in Heart Failure Subpopulations @JulioChirinosMd David E. Lanfear, MD MS Nancy Sweitzer MDPhD Folkert Asselbergs #AHAJournals ahajrnls.org/4ijStb7


Really happy to share our introductory guide to cardio-obstetrics in the CCU! We hope this will contribute to exceptional care for these patients Radcliffe Cardiology Amit Goyal MD MAS Ann Gage Kayle Shapero

A genetic variant in GRK4 significantly interacts with beta-blocker benefit in patients heart failure (and possibly other genetic variants as well): ascpt.onlinelibrary.wiley.com/doi/10.1111/ct… ASCPT Journal Family David E. Lanfear, MD MS Ana Lopez-Medina, PharmD, PhD PGRN CPIC ACCP PKPDPG PRN ACCP Cardiology PRN AHA Council on Genomic and Precision Medicine


Great kick off to #COMET-HF North American Investigator Meeting from Fady Malik MD PhD focused on the science behind omecamtiv mecarbil
